1. Home
  2. MEI vs STTK Comparison

MEI vs STTK Comparison

Compare MEI & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$15.78

Market Cap

560.5M

Sector

Technology

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.46

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
STTK
Founded
1946
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.5M
538.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MEI
STTK
Price
$15.78
$6.46
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$9.00
$10.00
AVG Volume (30 Days)
1.0M
1.7M
Earning Date
03-05-2026
05-01-2026
Dividend Yield
2.61%
N/A
EPS Growth
42.94
53.02
EPS
N/A
N/A
Revenue
$908,300,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.24
N/A
52 Week Low
$4.88
$0.71
52 Week High
$20.38
$8.33

Technical Indicators

Market Signals
Indicator
MEI
STTK
Relative Strength Index (RSI) 56.35 54.97
Support Level $6.31 $5.81
Resistance Level $20.38 $6.81
Average True Range (ATR) 1.78 0.65
MACD -0.28 0.07
Stochastic Oscillator 39.65 58.50

Price Performance

Historical Comparison
MEI
STTK

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: